Indian Railways gets its 300th high-speed freight locomotive from Alstom

The locomotives are part of a massive order of 800 WAG-12B engines signed by the Indian Railways and Alstom in 2018 valued at Rs 40,000 crore, spread over 10 years.

Moneycontrol News

March 29, 2023 / 18:39 IST

Planned to be deployed for operations on major freight routes, including the Dedicated Freight Corridors (DFCs), these electric locos are capable of hauling ~6,000 tonnes at a top speed of 120 kmph.

Indian Railways on March 29 received delivery of the 300th 12,000-HP (Horsepower) WAG-12B electric locomotive from Alstom.

The locomotives are part of a massive order of 800 WAG-12B engines signed by the Indian Railways and Alstom in 2018 valued at Rs 40,000 crore, spread over 10 years.

All 800 trains as part of the order will be delivered by 2028, and going forward 100 trains will be manufactured every year, as part of the contract.

The locomotive will be used for the faster movement of goods, especially coal and iron ore, as the Indian Railways looks to increase its market share in cargo movement in India.

"The Government of India is prioritising reducing logistics costs in its efforts to boost the economy towards the $ 5 trillion economy target. The Alstom WAG12B electric locomotive has proven to be a capability multiplier, with its ability to haul greater loads at faster speeds," Olivier Loison, Managing Director, Alstom India said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show